ENGNW
enGene Therapeutics Inc.
Set alert
0.18 USD 0.00 0.00%
0.1813 Day range 0.1831
0.1813 52-week range 0.1813
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 2.10
- Prev close
- 0.1813
- Mkt cap
- 9.28M
- Vol
- 2.31K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1813
- High
- 0.1831
- Forward P/E
- 0.00
- Beta
- -0.76
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.19
- EPS (TTM)
- 0.00
- Beta
- -0.76
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -23.58M
- Total cash
- 257.68M
- Total debt
- 24.86M
- Return on equity
- -123.06%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About enGene Therapeutics Inc.
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Guérin (BCG). The company is based in Montreal, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Canada
- Website
- engene.com
News
Your note
Sign in to keep a note on ENGNW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fcpm III Services B.v. | 27.64% | 2,878,148 | 2.79M | Sep 29, 2024 |
| BVF Inc. | 9.08% | 945,402 | 917.04K | Sep 29, 2024 |
| Blue Owl Capital Holdings LP | 4.91% | 511,177 | 495.84K | Sep 29, 2024 |
| Omega Fund Management, Llc | 3.09% | 321,502 | 311.86K | Sep 29, 2024 |
| Saba Capital Management, L.P. | 1.85% | 192,334 | 186.56K | Sep 29, 2024 |
| Calamos Advisors LLC | 1.44% | 150,000 | 145.50K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Saba Capital Income & Opportunities Fd | 0.06% | 6,044 | 5.86K | Jul 30, 2024 |